A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis

NCT05263817 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

75

Enrollment

OTHER

Sponsor class

Conditions

POEMS Syndrome
Amyloidosis
Autoimmune Hemolytic Anemia
Vasculitis

Interventions

BIOLOGICAL: CD19/BCMA CAR T-cells

Sponsor

Zhejiang University

Collaborators

[object Object]